Aflibercept in epithelial ovarian carcinoma

Author： Moroney John W   Sood Anil K   Coleman Robert L  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.5, 2009-06, pp. : 591-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

By Chi D.S.   Liao J.B.   Leon L.F.   Venkatraman E.S.   Hensley M.L.   Bhaskaran D.   Hoskins W.J.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 532-537

Elsevier

Access to resources Recommend Favorite

Secretion of Activin A in Recurrent Epithelial Ovarian Carcinoma

By Lambert-Messerlian G.M.   DePasquale S.E.   Maybruck W.M.   Steinhoff M.M.   Gajewski W.H.  

Gynecologic Oncology, Vol. 74, Iss. 1, 1999-07 ,pp. : 93-97

Elsevier

Access to resources Recommend Favorite

Epithelial Ovarian Carcinoma and European Birthplace of Grandparents

By Harlap S.   Olson S.   Akhmedkhanov A.   Barakat R.R.   Caputo T.   Sanchez D.   Xue X.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 25-32

Elsevier

Access to resources Recommend Favorite

Evaluation of Chemoresistance Markers in Women with Epithelial Ovarian Carcinoma

By Goff B.A.   Paley P.J.   Greer B.E.   Gown A.M.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 18-24

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian Carcinoma

By Scarabelli C.   Gallo A.   Carbone A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 504-512

Elsevier

Access to resources Recommend Favorite